Our Services
Medical Information
Helpful Resources
Published on: 2/7/2026
Adults 65 and older taking Ozempic can see improved blood sugar and weight, but GI side effects like nausea, diarrhea or constipation, and the risk of losing muscle are more likely and deserve extra care. Key steps include slow dose increases, small frequent meals with good hydration, prioritizing protein and gentle resistance exercise, watching for dehydration or sudden weakness, and knowing when to call your clinician; there are several factors to consider. See below for practical checklists, warning signs, and questions to ask your doctor that can guide your next steps.
Ozempic® (semaglutide) is widely used to help manage type 2 diabetes and, in some cases, support weight loss. For adults over 65, it can be effective—but it also deserves extra care. Aging bodies respond differently to medications, and Ozempic side effects related to the digestive system and muscle health are more common concerns in older adults.
This guide explains what to expect, why these issues happen, and practical ways to manage them—without alarm, but with honesty. Throughout, remember that individual risks vary. If anything feels serious or sudden, speak to a doctor promptly.
As we age, several normal changes can influence how medications work:
Ozempic works by mimicking a hormone (GLP‑1) that slows digestion, reduces appetite, and improves blood sugar control. These effects are helpful—but in people over 65, they can also increase the risk of gastrointestinal (GI) symptoms and unintentional muscle loss if not managed carefully.
Most people experience mild to moderate side effects when starting or increasing the dose. These often improve with time. Still, older adults may feel them more strongly.
The most common Ozempic side effects involve the stomach and intestines:
These happen because Ozempic slows how fast food leaves the stomach. For many, symptoms peak during the first few weeks or after a dose increase.
When to take extra care:
If these occur, contact a doctor—especially if you have heart, kidney, or blood pressure conditions.
Most GI side effects can be reduced with small, practical adjustments.
If symptoms persist beyond several weeks, your clinician may adjust the dose or explore other options.
Weight loss with Ozempic is common. However, in adults over 65, some of that weight can come from muscle, not just fat.
Muscle is essential for:
Age-related muscle loss already happens naturally. Appetite suppression from Ozempic can unintentionally speed it up if nutrition and activity are not addressed.
Muscle loss can be subtle at first. Watch for:
If you notice these changes, speak to a doctor. Early action can make a real difference.
The goal is not to stop weight loss—but to protect strength and function.
Older adults generally need more protein to maintain muscle.
Even light resistance can help preserve muscle.
Consistency matters more than intensity. A physical therapist can help design a safe plan.
Because Ozempic reduces appetite, it's easy to eat too little.
Sudden or excessive weight loss should be discussed with a healthcare professional.
While less common, it's important to be informed:
Rare but serious symptoms—such as severe abdominal pain, ongoing vomiting, or signs of allergic reaction—require urgent medical attention.
Sometimes it's hard to tell whether a symptom is medication-related, age-related, or something else. If you're experiencing new or concerning symptoms and aren't sure what to do next, using a Medically approved LLM Symptom Checker Chat Bot can help you better understand what you're experiencing and whether you should seek immediate care, schedule a doctor's visit, or continue monitoring at home.
Before or during Ozempic treatment, consider asking:
Open conversations help tailor treatment to your goals—not just the prescription.
For adults over 65, Ozempic can be a helpful medication—but it requires thoughtful management. Ozempic side effects, especially GI discomfort and muscle loss, are real concerns that deserve attention, not fear.
With:
many older adults use Ozempic safely and effectively.
If anything feels severe, sudden, or life‑threatening, speak to a doctor immediately. And if you're unsure what your symptoms mean, a guided symptom check may help you take the next right step—while keeping your health, strength, and independence front and center.
(References)
* Al-Ozairi, E., Abedini, A., Al-Salem, A., Mian, A., & Ahmad, S. (2022). Safety and Efficacy of Semaglutide in Older Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis. *Diabetes, Obesity and Metabolism, 24*(8), 1435–1447. PMID: 35502570.
* Wilding, J. P. H., Batterham, R. L., & Davies, M. J. (2023). Managing gastrointestinal adverse events associated with GLP-1 receptor agonists: a practical guide. *Postgraduate Medical Journal, 99*(1170), 223–231. PMID: 35437946.
* Sun, F., Zhou, W., Ma, F., An, Y., Ji, H., Sun, C., Li, S., & Li, C. (2020). Impact of GLP-1 receptor agonists on body composition in type 2 diabetes mellitus: A systematic review and meta-analysis. *Diabetes, Obesity and Metabolism, 22*(11), 2110–2121. PMID: 32677943.
* Han, E., & Kim, Y. (2022). Sarcopenia and metabolic diseases: The role of GLP-1 receptor agonists. *Frontiers in Endocrinology, 13*, 965251. PMID: 36147427.
* Al-Ozairi, E., & Khadadah, M. (2023). Semaglutide in older adults with obesity and type 2 diabetes: A review of current evidence. *Aging Medicine, 6*(1), 60–68. PMID: 36825000.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.